Tizanidine
Product Images NDC 50436-1180

5 FDA label images from Unit Dose Services · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 50436-1180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1)

Fig1 (Fig1)
A line graph depicting plasma tizanidine concentration (ng/mL) over 24 hours after dosing with four groups: 2 x 4 mg tizanidine tablets with food, without food, and 2 x 4 mg tizanidine capsules with and without food. The graph shows concentration peaks and declines for each group across time from dosing.*
FDA Label Image

Fig2 (Fig2)

Fig2 (Fig2)
Line graph depicting improvement in Ashworth Score over hours post-dose for 16 mg tizanidine, 8 mg tizanidine, and placebo. The y-axis represents improvement in Ashworth Score, and the x-axis shows hours post-dose from 0 to 6. Data points include error bars indicating variability for each treatment group over time.*
FDA Label Image

Fig3 (Fig3)

Fig3 (Fig3)
A chart depicting improvement in Ashworth Score comparing tizanidine (mean dose 28.8 mg) and placebo across three study points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The chart shows mean improvement with error bars for both treatment groups over time.*
FDA Label Image

Label Image (Lbl504361180)

Label Image (Lbl504361180)
Tizanidine Hydrochloride 4 mg tablets packaging label indicating a bottle containing 30 tablets. Label states each tablet contains 4 mg of tizanidine base. Manufactured by Dr. Reddy's Laboratories Limited, India, and packaged by Unit Dose Services, LLC, FL. Includes NDC 50436-1180-1 and warnings about storage conditions and child safety. Label version Rev. 1 and marked as RX only.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of Tizanidine hydrochloride, showing the molecular arrangement of atoms in the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.